These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27832160)

  • 1. Proteomic Signatures of Thymomas.
    Wang L; Branson OE; Shilo K; Hitchcock CL; Freitas MA
    PLoS One; 2016; 11(11):e0166494. PubMed ID: 27832160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.
    Kim DJ; Yang WI; Kim SH; Park IK; Chung KY
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):611-6. PubMed ID: 16125946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
    Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
    Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
    Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
    Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.
    Sun QL; Fang WT; Feng J; Zhang J; Yang XH; Gu ZT; Zhu L; Sha HF
    Chin Med J (Engl); 2012 Aug; 125(16):2811-8. PubMed ID: 22932072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilocular thymic cyst associated with thymoma: a clinicopathologic study of 20 cases with an emphasis on the pathogenesis of cyst formation.
    Nakamura S; Tateyama H; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Mizuno T; Ishiguro F; Yokoi K
    Am J Surg Pathol; 2012 Dec; 36(12):1857-64. PubMed ID: 23026930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of cytokeratin 34beta E12 in thymoma: could it be a poor prognosis factor?
    Cîmpean AM; Raica M; Encica S
    Rom J Morphol Embryol; 1999-2004; 45():153-7. PubMed ID: 15847389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.
    Penzel R; Hoegel J; Schmitz W; Blaeker H; Morresi-Hauf A; Aulmann S; Hecker E; Mechtersheimer G; Otto HF; Rieker RJ
    Int J Cancer; 2003 Jul; 105(4):494-8. PubMed ID: 12712440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of thymic epithelial tumor subtypes by a quantitative proteomic approach.
    Zhao T; Wu J; Liu X; Zhang L; Chen G; Lu H
    Analyst; 2018 May; 143(11):2491-2500. PubMed ID: 29645059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticomedullary differentiation and maturational arrest in thymomas.
    Ströbel P; Hartmann E; Rosenwald A; Kalla J; Ott G; Friedel G; Schalke B; Kasahara M; Tomaru U; Marx A
    Histopathology; 2014 Mar; 64(4):557-66. PubMed ID: 24236644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
    Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1, PD-1, CD4, and CD8 expression in neoplastic and nonneoplastic thymus.
    Marchevsky AM; Walts AE
    Hum Pathol; 2017 Feb; 60():16-23. PubMed ID: 27746267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of proteasome subunit β5t in thymic epithelial tumors.
    Yamada Y; Tomaru U; Ishizu A; Kiuchi T; Marukawa K; Matsuno Y; Kasahara M
    Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome.
    Tateyama H; Sugiura H; Yamatani C; Yano M
    Hum Pathol; 2011 Apr; 42(4):533-40. PubMed ID: 21237498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thymomas].
    Marx A; Weis CA; Ströbel P
    Pathologe; 2016 Sep; 37(5):412-24. PubMed ID: 27558364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of thymoma by fine needle aspiration biopsy according to WHO classification: a cytological algorithm for stepwise analysis in the classification of thymoma.
    Ryu HS; Koh JS; Park S; Kim MS; Cho SY; Lee SS
    Acta Cytol; 2012; 56(5):487-94. PubMed ID: 23075888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of p63 and XIAP in thymic hyperplasia and thymomas.
    Wu M; Sun K; Gil J; Gan L; Burstein DE
    Am J Clin Pathol; 2009 May; 131(5):689-93. PubMed ID: 19369629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.